James Hardie Reports 25% Sales Growth and Board Changes Ahead of 2026 AGM

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.

  • FY26 sales surged 25% to $4.8 billion
  • Board refreshed with new director Rob Sindel
  • Chair Nigel Stein seeks re-election with Class III transition
  • Executive compensation redesigned after shareholder feedback
  • AGM scheduled for August 20, 2026, in Dublin with teleconference access
An image related to James Hardie Industries PLC
Image © middle. Logo © respective owner.

Strong Sales Growth Anchored by AZEK Acquisition

James Hardie Industries (ASX:JHX) reported a 25% jump in net sales to $4.8 billion for fiscal year 2026, driven largely by the acquisition of The AZEK Company in July 2025. The integration of AZEK’s outdoor living products has expanded James Hardie’s market footprint, particularly in North America, where the combined business now commands a $5 billion home exteriors and outdoor living materials platform.

Despite a challenging macroeconomic backdrop, the company delivered adjusted EBITDA of $1.27 billion and free cash flow of $314 million, with cost synergies from the AZEK deal progressing ahead of schedule. However, net income fell 75% to $104 million, impacted by acquisition-related expenses, inventory fair value adjustments, and increased amortisation of intangible assets.

Board Renewal and Governance Enhancements

The 2026 AGM agenda reflects a refreshed board, with the appointment of Rob Sindel, former CEO of CSR Limited and chair of Mirvac and Orora, bringing additional Australian expertise and investor relations experience. Chair Nigel Stein, who took over in November 2025 following shareholder dissent at last year’s AGM, is standing for re-election and plans to transition to a Class III director role, meaning he will face re-election again in 2027 to enhance board accountability.

The board has responded to shareholder feedback by strengthening engagement and governance, including a proposal to amend the Articles of Association to apply classified board provisions consistently to all directors, including the CEO, aligning with US-listed company practices.

Executive Pay Restructuring Reflects Shareholder Concerns

Following a disappointing 34% support vote on the FY25 remuneration report, the People & Compensation Committee undertook extensive shareholder engagement and redesigned the executive compensation program for FY27. The new structure reduces cash-settled long-term incentives, caps maximum payouts to 200% of target, simplifies performance metrics, and introduces stock options to align pay with sustainable share price appreciation.

The FY26 executive compensation included significant negative discretion applied by the committee, with the CEO’s short-term incentive plan paying out at 48% of target and long-term incentive awards vesting only if rigorous three-year goals are met. The FY26 CEO equity grant for 2027 awaits shareholder approval at the upcoming AGM.

AGM Details and Shareholder Proposals

The AGM is scheduled for August 20, 2026, at James Hardie’s Dublin headquarters, with teleconference access for shareholders to listen and ask questions, though voting must be done in person or by proxy. Key proposals include election and re-election of directors, advisory votes on executive compensation frequency and approval, CEO equity grants, securities issuance under the Non-Executive Director Equity Plan, an increase to the Non-Executive Director fee pool, approval of financial statements, ratification of Ernst & Young LLP as external auditor, and governance amendments.

Shareholders are urged to consider the board’s recommendations, which support all director elections, advisory votes for annual executive pay approvals, CEO equity grants, and financial statement approvals. The board abstains from recommending on the Non-Executive Director fee pool increase due to potential personal interests.

Legal and Regulatory Risks Remain Under Watch

James Hardie continues to face asbestos-related liabilities managed through the Asbestos Injuries Compensation Fund in Australia, with liabilities estimated at over $1 billion. The company also faces class action lawsuits in Australia and the US related to alleged disclosure breaches and the AZEK acquisition. Management maintains these claims are without merit and plans vigorous defense.

Other operational risks include raw material cost volatility, supply chain challenges, and regulatory compliance across multiple jurisdictions. The company’s dual listing on the NYSE and ASX adds complexity to reporting and governance.

What to Watch Next

The market will be closely watching the August AGM outcomes, particularly the re-election of Chair Nigel Stein and the approval of the redesigned executive pay structure. Progress on AZEK integration synergies and cost savings, including the impact of recent plant closures, will be critical to watch as James Hardie seeks to restore profitability and confidence. Legal developments around the ongoing class actions and asbestos liabilities also remain key uncertainties for investors.

Bottom Line?

James Hardie’s FY26 marks a pivotal integration year with board renewal and pay reform setting the stage for a critical AGM and operational execution phase.

Questions in the middle?

  • Will shareholders endorse the Chair’s re-election and the new executive pay framework at the AGM?
  • How swiftly will James Hardie convert AZEK integration synergies into margin expansion?
  • What impact will ongoing asbestos and securities litigation have on the company’s financial and reputational standing?